![Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/90ff069c-1076-4be9-922e-3f762a514f3b/gr1.gif)
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology
![Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials - Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -](https://www.thelancet.com/cms/asset/9dffa94a-4098-4902-bf61-ec9a648d6467/gr1.jpg)
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -
Resuming or reforming? Tracking the global impact of the COVID-19 pandemic on higher education after two years of disruption
![Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines | Pharmacological Reviews Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/74/1/313/F3.large.jpg)
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines | Pharmacological Reviews
![Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario - Ontario COVID-19 Science Advisory Table Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario - Ontario COVID-19 Science Advisory Table](https://covid19-sciencetable.ca/wp-content/uploads/2021/11/Figure-1.png)
Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario - Ontario COVID-19 Science Advisory Table
![The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet](https://www.thelancet.com/cms/attachment/c652217f-870a-4a98-976d-c433af9ee115/gr1.jpg)
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
![Cancers | Free Full-Text | HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study Cancers | Free Full-Text | HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study](https://pub.mdpi-res.com/cancers/cancers-13-04149/article_deploy/html/images/cancers-13-04149-g001.png?1629286783)
Cancers | Free Full-Text | HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study
![Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines | Pharmacological Reviews Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/74/1/313/F1.large.jpg)
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines | Pharmacological Reviews
![Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test - ScienceDirect Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004221013900-fx1.jpg)
Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test - ScienceDirect
![IJERPH | Free Full-Text | Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries IJERPH | Free Full-Text | Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries](https://www.mdpi.com/ijerph/ijerph-19-07233/article_deploy/html/images/ijerph-19-07233-g001-550.jpg)
IJERPH | Free Full-Text | Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries
![COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes | Clinical Microbiology Reviews COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes | Clinical Microbiology Reviews](https://journals.asm.org/cms/asset/f8055cec-8574-4e33-a738-0492d6803dea/cmr.2022.35.issue-3.cover.gif)